© 2023 澳门正规博彩十大排行平台. All rights reserved.

Back to Leadership

Jeff Ajer joined 澳门正规博彩十大排行平台 in August 2005 and currently serves as our Chief Commercial Officer. From October 2012 to January 2014, Mr. Ajer served as our Senior Vice President and Chief Commercial Officer. From April 2009 to October 2012, he served as our Vice President, Commercial Operations, The Americas, where he had responsibility for commercial operations throughout the Americas and led product marketing, reimbursement, and sales operations for 澳门正规博彩十大排行平台.

Prior to joining 澳门正规博彩十大排行平台, Mr. Ajer served in various roles at Genzyme Corporation (Genzyme) beginning in November 2003, most recently as Vice President, Global Transplant Operations from December 2004 to August 2005. His experience prior to Genzyme includes roles in sales, marketing and operations at SangStat Medical Corporation and ICN Pharmaceuticals.

Mr. Ajer received both a B.S. in chemistry and an M.B.A. from the University of California, Irvine. Mr. Ajer is currently a director of Nektar Therapeutics, a public biopharmaceutical company. He also serves as executive Leader Liaison to the 澳门正规博彩十大排行平台 Women’s Leadership Development (BWLD) Employee Resource Group.


Our Pipeline

We maximize the impact of genetic innovation to develop transformative therapies.

We recently presented an update on our pipeline at our 2023 R&D Day. View the replay on our Investor Relations site.

View Now Our Pipeline